Moolec Science SA (MLEC)
NASDAQ: MLEC · IEX Real-Time Price · USD
1.460
-0.270 (-15.61%)
At close: Apr 24, 2024, 4:00 PM
1.395
-0.065 (-4.45%)
Pre-market: Apr 25, 2024, 7:37 AM EDT
Company Description
Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming.
It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product.
It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.
Moolec Science SA
| Country | Luxembourg |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 45 |
| CEO | Gaston Paladini M.B.A. |
Contact Details
Address: 17, Boulevard F.w. Raiffeisan Luxembourg, N4 L-2411 Luxembourg | |
| Phone | 352 26 49 65 65 |
| Website | moolecscience.com |
Stock Details
| Ticker Symbol | MLEC |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001937737 |
| ISIN Number | LU2559000059 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Gaston Paladini M.B.A. | Co-Founder, Chief Executive Officer and Director |
| Henk Hoogenkamp Ph.D. | Co-Founder and Chief Product Officer |
| Martin Salinas Ph.D. | Chief of Technology and Co-Founder |
| Jose Lopez Lecube M.B.A. | Chief Financial Officer and Director |
| Amit Dhingra Ph.D. | Chief Science Officer |
| Catalina Jones B.A. | Chief of Staff and Sustainability |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 23, 2024 | 6-K | Report of foreign issuer |
| Apr 18, 2024 | 6-K | Report of foreign issuer |
| Apr 17, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Apr 10, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Mar 12, 2024 | 6-K | Report of foreign issuer |
| Feb 26, 2024 | 6-K | Report of foreign issuer |
| Feb 15, 2024 | 424B3 | Prospectus |
| Feb 15, 2024 | 424B3 | Prospectus |
| Jan 22, 2024 | 6-K | Report of foreign issuer |
| Jan 16, 2024 | 424B3 | Prospectus |